Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Paravertebral Block for Chronic Pain After Breast Cancer Surgery
NCT02408393Phase 3Completed
- Sponsor
- Institut Curie
- Start
- Mar 2015
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in chronic post-surgical pain (CPSP), sponsored by Institut Curie. Started Mar 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
chronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT02408393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408393.